Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124135602 | 12413560 | 2 | F | 20160520 | 20160627 | 20160527 | 20160706 | EXP | JP-CELGENEUS-JPN-2016056542 | CELGENE | 70.00 | YR | M | Y | 65.00000 | KG | 20160706 | OT | US | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124135602 | 12413560 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 21660 | 210 | MG | INJECTION FOR INFUSION | ||||||
| 124135602 | 12413560 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | 180 MILLIGRAM | Y | U | 21660 | 170 | MG | INJECTION FOR INFUSION | QD | ||||
| 124135602 | 12413560 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 55974 | 1700 | MG | INJECTION | ||||||
| 124135602 | 12413560 | 4 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | 25 MILLIGRAM | Y | U | 55974 | 1350 | MG | INJECTION | QD | ||||
| 124135602 | 12413560 | 5 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124135602 | 12413560 | 6 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 0 | 25 | MG | UNKNOWN | QD | |||||||
| 124135602 | 12413560 | 7 | C | Loxonin | LOXOPROFEN SODIUM | 1 | Oral | 0 | 180 | MG | UNKNOWN | QD | |||||||
| 124135602 | 12413560 | 8 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | 20 | MG | UNKNOWN | QD | |||||||
| 124135602 | 12413560 | 9 | C | Mucosta | REBAMIPIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124135602 | 12413560 | 10 | C | Novamin | PROCHLORPERAZINE MALEATE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124135602 | 12413560 | 1 | Pancreatic carcinoma |
| 124135602 | 12413560 | 3 | Pancreatic carcinoma |
| 124135602 | 12413560 | 5 | Product used for unknown indication |
| 124135602 | 12413560 | 6 | Diabetes mellitus |
| 124135602 | 12413560 | 7 | Product used for unknown indication |
| 124135602 | 12413560 | 8 | Rheumatoid arthritis |
| 124135602 | 12413560 | 9 | Product used for unknown indication |
| 124135602 | 12413560 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124135602 | 12413560 | HO |
| 124135602 | 12413560 | LT |
| 124135602 | 12413560 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124135602 | 12413560 | Dyspnoea | |
| 124135602 | 12413560 | Full blood count decreased | |
| 124135602 | 12413560 | Interstitial lung disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124135602 | 12413560 | 1 | 20160328 | 0 | ||
| 124135602 | 12413560 | 2 | 20160425 | 20160509 | 0 | |
| 124135602 | 12413560 | 3 | 20160328 | 0 | ||
| 124135602 | 12413560 | 4 | 20160425 | 20160509 | 0 | |
| 124135602 | 12413560 | 6 | 201401 | 0 | ||
| 124135602 | 12413560 | 7 | 201401 | 0 | ||
| 124135602 | 12413560 | 8 | 201603 | 0 |